ADVFN Logo

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

SAN Sanofi

87.31
-0.58 (-0.66%)
01 Mar 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Sanofi SAN Euronext Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.58 -0.66% 87.31 10:40:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
88.45 87.09 88.52 87.31 87.89
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/2/202408:51GLOBECommuniqué : Résultats de phase II montrent que le..
23/2/202411:45GLOBEPress Release: Filing of the 2023 U.S. Form 20-F and French..
23/2/202400:00GLOBECommuniqué de presse : La FDA accorde un examen prioritaire..
22/2/202412:02GLOBEPress Release: Sanofi’s Board of Directors proposes the..
20/2/202416:40GLOBESanofi: Informations relatives au nombre de droits de vote..
16/2/202400:00GLOBECommuniqué de presse : Le Japon est le premier pays dans le..
15/2/202407:00GLOBEPress Release: Phase 2 data published in NEJM show potential..
05/2/202401:00GLOBECommuniqué de presse : Entraide, conditions de travail..
01/2/202400:30GLOBECommunique de presse - 2023 : Croissance des ventes et du..
25/1/202413:30GLOBECommuniqué de presse : Dupixent® : premier et seul..
23/1/202405:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
23/1/202400:30GLOBECommuniqué de presse : Sanofi va acquérir Inhibrx, Inc. et..
17/1/202415:57GLOBESanofi: Informations relatives au nombre de droits de vote..
09/1/202401:14DJNSanofi Names Brian Foard Head of Specialty-Care Unit
09/1/202400:30GLOBEPress Release: Brian Foard appointed Head of Specialty Care..
21/12/202301:25DJNSanofi Ends Drug Program After Late-Stage Trial in Lung..
21/12/202300:30GLOBEPress Release: Sanofi announces end of program evaluating..
19/12/202306:28DJNInnate Pharma Shares Rise after Sanofi Exercises Licensing..
18/12/202314:59GLOBESanofi: Information concerning the total number of voting..
15/12/202300:30GLOBECommuniqué de presse : Mise en ligne du document «Q4 2023..
15/12/202300:00GLOBEPress Release: EMA gives positive opinion to Fexinidazole..
11/12/202316:18DJNSanofi Terminates Agreement with Maze Therapeutics Following..
11/12/202315:08GLOBEPress Release: Statement on FTC challenge to proposed..
11/12/202300:50DJNSanofi Sees Improvement in Trial Results of Cancer Drug..
10/12/202318:30GLOBECP : Sarclisa® (isatuximab) plus KRd améliore..
07/12/202301:34DJNSanofi Myeloma Drug Sarclisa Met Primary Goal in Late-Stage..
07/12/202301:20DJNSanofi Sees Annual Sales From New Pharma Assets Above $10.8..
07/12/202300:35GLOBECP : L’essai de phase III consacré au Sarclisa® (isatuximab)..
06/12/202320:30GLOBEPress Release: Sanofi Pipeline Transformation to Accelerate..
06/12/202307:20DJNTrending: Merck's Multiple Sclerosis Drug Misses..
06/12/202304:14DJNMerck Shares Slump After Multiple Sclerosis Drug Fails in..
30/11/202308:23DJNTeva Closes Collaboration Deal With Sanofi on IBD Treatment
27/11/202309:31DJNTrending: Sanofi's Notus Trial Meets Primary Endpoint
27/11/202301:40DJNSanofi Says Notus Phase 3 Trial of Dupixent Met Primary..
27/11/202300:30GLOBECommuniqué de presse : Dupixent® a permis de réduire..
23/11/202311:00GLOBESanofi: Information concerning the total number of voting..
07/11/202307:56DJNSanofi Under Preliminary Probe in France Over Possible..
30/10/202307:14DJNMeiraGTx Gets $30 Million Investment From Sanofi
27/10/202310:47DJNSanofi Down Over 19%, on Pace for Record Percent Decrease --..
27/10/202303:43DJNSanofi Shares Tumble After Warning of Profit Hit From..
27/10/202301:54DJNSanofi Backs Guidance After Earnings, Sales Miss Views
27/10/202301:35DJNSanofi Plans to Split Consumer-Healthcare, Pharma Businesses..
27/10/202301:07DJNSanofi Plans to Spin Off Consumer-Healthcare Business
27/10/202300:31GLOBEPress Release: Specialty Care growth, strong launch uptake..
27/10/202300:30GLOBECommuniqué de presse : Sanofi entame un nouveau chapitre de..
22/10/202314:00GLOBEPress Release: Dupixent® (dupilumab) Phase 3 Results show..
22/10/202313:59GLOBEDupixent® (dupilumab) Phase 3 Results Show Sustained..
19/10/202305:00GLOBECommuniqué de presse : Sanofi livre les premiers médicaments..
18/10/202304:40DJNSanofi Says Drug Shows Potential to Slow Diabetes in..
18/10/202303:45GLOBECommuniqué de presse : Des données de ph III présentées au..

Su Consulta Reciente

Delayed Upgrade Clock

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

Support: (55) 4170 8128 | soporte@advfn.mx